Schedule
All schedule times are Eastern Time.
Please note that program changes / substitutions may be made without notice.
New Key 1
New Key 2
New Key 3
Optional Pre-Course Workshop: Making Health Care Affordable
Friday, May 24, 2030
Part 1: How We Got Here
Breakouts
Speaker
8:45 to 9:45 am
Breakout Title Test
A1
Test 1
test test
Title of session
Speaker
9:45 to 10:45 am
Break
10:45 to 11:00 am
Part 2: Why We Still Try
This is a subtitle
Title of session
Speaker
11:00 to 11:45 am
Title of session
Speaker
11:45 am to 12:45 pm
New Key 1
New Key 2
New Key 3
Day 1
Saturday, May 25, 2030
Welcome
8:00-8:15 am
Medical Treatment of Obesity - Updates and Best Practices for Individualizing Therapies
8:15-8:45 am
Advances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes
8:45-9:15 am
Q & A and Clinical Case Discussion
9:15-10:00 am
Break
10:10-10:15 am
CARDIOVASCULAR: Diagnosis and Management of Heart Failure in the Patient with Diabetes – What every physician now needs to know
10:15-11:05 am
METABOLIC: Technological advances in diabetes care
10:15-11:05 am
Artificial Intelligence in Cardiometabolic Disease
11:05-11:55 am
Closing Remarks
11:55 am-12:00 pm
New Key 1
New Key 2
New Key 3
Day 2
Sunday, May 26, 2030
Welcome
8:00-8:05 am
New clinical models in diabetes care
8:05-8:40 am
Updates in the Prevention and Management of Hypoglycemia
8:40-9:15 am
Q & A and Clinical Case Discussion
9:15-10:00 am
Break
10:00-10:15 am
Diagnosis and Management of Coronary Artery Disease in the patient with diabetes: Practical tools for the busy clinician
10:15-11:05 am
Sleeping disorders and metabolic disease
10:15-11:05 am
Break
11:05-11:10 am
Hypertension management in the patient with diabetes
11:10-11:55 am
Closing Remarks
11:55 am-12:00 pm
New Key 1
New Key 2
New Key 3
Day 3
Monday, May 27, 2030
Welcome
8:00-8:05 am
Practical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction
8:05-8:30 am
The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular and Renal Disease – Implications for Clinical Practice
8:30-8:55 am
The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes- Recent Data and Practical Implications
8:55-9:20 am
Q & A and Clinical Case Discussion
9:20-10:00 am
Break
10:00-10:15 am
Updates, innovations and advances for the management of dyslipidemia in the patient with diabetes
10:15-11:10 am
Management of diabetes in adolescents and young adults
10:15-11:10 am
THE EDWARD S. HORTON KEYNOTE LECTURE
11:10-11:55 am
Closing Remarks
11:55 am-12:00 pm
New Key 1
New Key 2
New Key 3
Day 4
Tuesday, May 28, 2030
WELCOME, RECAP OF DAY 3, INTRODUCTION TO DAY 4 ACTIVITIES
8:00-8:05 am
Evaluation and Monitoring of Diabetic CKD
8:05-8:40 am
Current Clinical Guidelines for the Management of CKD in Diabetes
8:40-9:15 am
Q & A and Clinical Case Discussion
9:15-10:00 am
Break
10:00-10:15 am
Pros and Cons of common cardiovascular disease diagnostic tests
10:15-11:05 am
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
10:15-11:05 am
INSULIN THERAPY IN 2025. IS THERE STILL A ROLE?
11:05-11:55 am
Closing Remarks
11:55 am-12:00 pm